Loading...
Loading...
Among the 2 tracked institutional investors we monitor, EPRX (EUPRAXIA PHARMACEUTICALS INC) is held with a combined value of $8.67M across 1,197,751 shares. The largest holder is Point72 Asset Management, L.P. with a position worth $7.01M (0.01% of their portfolio). CITADEL ADVISORS LLC opened a new position in the most recent quarter. 1 fund increased its holdings.
Total Institutional Value
$8.67M
Total Shares Held
1,197,751
Institutional Holders
2
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | $7.01M | 0.01% | +35.9% |
| 2 | CITADEL ADVISORS LLC | $1.67M | 0.00% | New |
As of the latest SEC 13F filings, Point72 Asset Management, L.P. is the largest institutional holder of EPRX with a position worth $7.01M, representing 0.01% of their portfolio. In total, 2 institutional investors hold EPRX with a combined value of $8.67M.
In the most recent quarter, 1 fund opened a new position in EPRX. Additionally, 1 increased their holdings.
Institutional investors hold $8.67M worth of EPRX stock across 2 positions. The largest institutional holder is Point72 Asset Management, L.P. with $7.01M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For EPRX, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their EPRX positions.